A detailed history of Assetmark, Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 43,906 shares of AMPH stock, worth $1.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
43,906
Previous 40,256 9.07%
Holding current value
$1.98 Million
Previous $1.61 Million 32.3%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$36.99 - $50.09 $135,013 - $182,828
3,650 Added 9.07%
43,906 $2.13 Million
Q2 2024

Aug 13, 2024

BUY
$38.65 - $43.48 $173,113 - $194,746
4,479 Added 12.52%
40,256 $1.61 Million
Q1 2024

May 06, 2024

SELL
$42.85 - $63.45 $428 - $634
-10 Reduced 0.03%
35,777 $1.57 Million
Q4 2023

Feb 09, 2024

BUY
$44.49 - $62.93 $204,476 - $289,226
4,596 Added 14.74%
35,787 $2.21 Million
Q3 2023

Oct 27, 2023

BUY
$45.51 - $65.0 $4,277 - $6,110
94 Added 0.3%
31,191 $1.43 Million
Q2 2023

Aug 11, 2023

BUY
$35.77 - $58.38 $50,936 - $83,133
1,424 Added 4.8%
31,097 $1.79 Million
Q1 2023

May 05, 2023

BUY
$27.99 - $37.92 $48,338 - $65,487
1,727 Added 6.18%
29,673 $1.11 Million
Q4 2022

Feb 10, 2023

BUY
$27.93 - $31.27 $50,665 - $56,723
1,814 Added 6.94%
27,946 $783,000
Q3 2022

Nov 01, 2022

BUY
$27.56 - $37.75 $720,197 - $986,483
26,132 New
26,132 $734,000
Q1 2018

May 16, 2018

SELL
$17.23 - $20.35 $189 - $223
-11 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$17.76 - $19.75 $106 - $118
6 Added 120.0%
11 $0
Q4 2016

Sep 15, 2017

BUY
N/A
5
5 $0

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.21B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.